trending Market Intelligence /marketintelligence/en/news-insights/trending/pfjonr_ugsga9kpthbtnig2 content esgSubNav
In This List

Elite Pharmaceuticals adds director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Elite Pharmaceuticals adds director

Northvale, N.J.-based Elite Pharmaceuticals Inc. appointed Aqeel Fatmi to its board as an independent director.

Fatmi previously held roles at Humanwell Healthcare Group, Banner Pharmacaps and Patheon Pharmaceuticals Inc.

Elite Pharmaceuticals develops and sells proprietary orally administered controlled-release drug delivery systems and products.